Cerebroprotein Hydrolysate PCD Pharma Franchise Company
Cafoli Lifecare offers a Cerebroprotein Hydrolysate range of 5 formulations across injection and tablets, manufactured in WHO-GMP certified facilities. Distributors serving neurology and neuro-rehabilitation prescribers can secure district-wise monopoly franchise rights for this neurotrophic molecule with full promotional support.
What is Cerebroprotein Hydrolysate?
Cerebroprotein hydrolysate is a mixture of low-molecular-weight peptides and amino acids with neurotrophic activity. It is used as a supportive nootropic and neuroprotective agent, intended to aid neuronal function and recovery in conditions such as stroke, traumatic brain injury and dementia. Reference: PubMed - Cerebroprotein hydrolysate.
Available Forms
The Cafoli Cerebroprotein Hydrolysate portfolio includes Injection in various strengths (30mg, 60mg, 90mg) for clinician administration and oral Tablets for maintenance. Contact us for current pack presentations and combinations.
Therapeutic Applications
Cerebroprotein hydrolysate is used as adjuvant, supportive therapy in ischaemic stroke recovery, traumatic brain injury, dementia and cognitive impairment, and other neurological conditions. Prescribers are chiefly neurologists, neurosurgeons and physicians involved in neuro-rehabilitation.
Why Cerebroprotein Hydrolysate is a High-Potential Molecule for Distributors
Neurotrophic agents are a specialist, higher-value niche prescribed by neurologists for extended courses during stroke and brain-injury rehabilitation. With rising stroke incidence and growing neuro-rehab awareness in India, cerebroprotein hydrolysate offers a distributor a differentiated, limited-competition neuro line with strong per-course value from both hospital injectables and maintenance tablets.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.
References
- PubMed: cerebroprotein hydrolysate in stroke
- PubMed: neurotrophic peptide preparations
- MedlinePlus: Stroke
Our formulations of Cerebroprotein Hydrolysate find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: